Global Deep Brain Stimulation Devices Market - Strategic Insights and Forecasts (2026-2035)

The Deep Brain Stimulation Devices Market is projected to grow from USD 420.24 million in 2026 to USD 871.76 million by 2035, expanding at a CAGR of 8.5% during the forecast period.

The Deep Brain Stimulation Devices Market is driven by rising Parkinson’s disease prevalence, increasing movement disorder cases in aging populations, medication-resistant motor complications, and growing adoption of advanced neuromodulation systems.

The Deep Brain Stimulation Devices Market faces restraints such as high procedural and device costs, limited availability of specialized neurosurgical centers, surgical risks, and long-term programming complexity.

North America leads the Deep Brain Stimulation Devices Market due to advanced neurosurgical infrastructure, strong reimbursement systems, early technology adoption, and the presence of major device manufacturers.

Key participants in the Deep Brain Stimulation Devices Market include Medtronic, Abbott Laboratories, Boston Scientific, NeuroPace, and Newronika.